13F-HRCIK 0001165408
Last filed Aug 14, 2026Adage Capital Partners GP, L.L.C.·13F Holdings
$58.6B+13.1% vs prior quarter
- Positions
- 476
- Top-10 weight
- 36%
- Largest
- NVDA · 7.5%
- Quarter ending
- Jun 30, 2026
- Added
- 226
- Trimmed
- 247
- Sold out
- 31
- Last filed
- Aug 14, 2026
Portfolio
What does Adage Capital Partners GP, L.L.C. own?
Adage Capital Partners GP, L.L.C. reported 476 long equity positions worth $58.6B for the quarter ending Jun 30, 2026. The largest is NVDA at 7.5% of reported value. The ten largest positions make up 36% of the portfolio. Against the prior quarter it added to 226 positions, trimmed 247 and sold out of 31. The latest 13F was filed Aug 14, 2026.
Largest positionsValue · weight
- NVDANVIDIA Corporation$4.4B7.5% of portfolio
- AAPLApple Inc.$3.8B6.4% of portfolio
- MSFTMicrosoft Corporation$2.5B4.2% of portfolio
- AMZNAmazon.com, Inc.$2.1B3.6% of portfolio
- GOOGLAlphabet Inc.$1.9B3.2% of portfolio
- AVGOBroadcom Inc.$1.6B2.7% of portfolio
- GOOGAlphabet Inc.$1.5B2.5% of portfolio
- MUMicron Technology, Inc.$1.2B2.0% of portfolio
- METAMeta Platforms, Inc.$1.2B2.0% of portfolio
- TSLATesla, Inc.$1.0B1.8% of portfolio
Sector tilt
Which sectors does Adage Capital Partners GP, L.L.C. lean on?
Technology (36%) and Healthcare (10%) are the two largest sectors by reported value.
By share of reported value, across 476 classified tickers.
Quarter changes
What did Adage Capital Partners GP, L.L.C. buy and sell last quarter?
Largest additions last quarterEst. value
Reported value
How has Adage Capital Partners GP, L.L.C.'s 13F value moved?
Reported value went from $41.7B to $58.6B over 10 quarters. It moves with prices and with buying and selling, so it is not a fund return.
$41.7BMar 2024
$42.2BJun 2024
$44.3BSep 2024
$45.7BDec 2024
$42.7BMar 2025
$48.0BJun 2025
$52.0BSep 2025
$53.4BDec 2025
$51.8BMar 2026
$58.6BJun 2026
Latest 13F
What Adage Capital Partners GP, L.L.C. changed in its latest 13F
| Company | Change | Shares vs prior | Est. value | Filed |
|---|---|---|---|---|
| Revolution Medicines, Inc. RVMD | -89% | $913.6M | Aug 14, 2026 | |
| Devon Energy Corporation DVN | +904% | $314.3M | Aug 14, 2026 | |
| Eli Lilly and Company LLY | -24% | $276.6M | Aug 14, 2026 | |
| RB Global Inc. RBA | -92% | $241.7M | Aug 14, 2026 | |
| CSX Corporation CSX | -70% | $236.6M | Aug 14, 2026 | |
| Astera Labs, Inc. ALAB | -80% | $176.3M | Aug 14, 2026 | |
| Marvell Technology Inc. MRVL | +288% | $164.9M | Aug 14, 2026 | |
| United Airlines Holdings, Inc. UAL | +458% | $133.8M | Aug 14, 2026 | |
| Chevron Corporation CVX | -31% | $128.7M | Aug 14, 2026 | |
| Boston Scientific Corporation BSX | -64% | $126.5M | Aug 14, 2026 | |
| BridgeBio Pharma Inc. BBIO | +276% | $123.1M | Aug 14, 2026 | |
| Unum Group UNM | -68% | $120.7M | Aug 14, 2026 | |
| Axsome Therapeutics Inc. AXSM | -65% | $117.1M | Aug 14, 2026 | |
| The Southern Company SO | -100% | $114.6M | Aug 14, 2026 | |
| Dover Corporation DOV | +70% | $112.8M | Aug 14, 2026 |
